Pharmacology of Desmin (low molecular weight Dermatan sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg)

Author： Dettori A.G.   Milani M.R.   Manotti C.   Zamboni V.   Palazzini E.   Barbanti M.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.79, Iss.3, 1995-08, pp. : 249-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PHARMACOLOGY OF A NEW LOW MOLECULAR WEIGHT DERMATAN SULPHATE (DESMIN) IN HEALTHY VOLUNTEERS: REPEATED DAILY INTRAMUSCULAR ADMINISTRATION OF 400 mg FOR A WEEK

By Dettori A.G.   Zamboni V.   Manotti C.   Canova N.   Barbanti M.   Palazzini E.  

Thrombosis Research, Vol. 83, Iss. 1, 1996-07 ,pp. : 103-109

Elsevier

Access to resources Recommend Favorite

THE TREATMENT OF DEEP VEIN THROMBOSIS WITH CONTINUOUS INTRAVENOUS LOW-MOLECULAR-WEIGHT DERMATAN SULPHATE (DESMIN). A PILOT STUDY

By Kretz J.-G.   Chakfe N.   Wiesel M.-L.   Grunebaum L.   Zamboni V.   Palazzini E.   Cazenave J.-P.  

Thrombosis Research, Vol. 84, Iss. 6, 1996-12 ,pp. : 391-398

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of Low Molecular Weight Dermatan Sulphate (Desmin) in Different Cohorts of Patients - An interactive graphic program for individual and population pharmacokinetic parameters estimation

By Saivin S.   Carrie D.   Escourrou J.   Duchene P.   Zamboni V.   Barbanti M.   Palazzini E.   Houin G.  

Thrombosis Research, Vol. 90, Iss. 3, 1998-05 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite

THROMBOLYSIS ENHANCING ACTIVITY OF A LOW MOLECULAR WEIGHT DERMATAN SULFATE (DESMIN 370) IN EXPERIMENTAL PULMONARY EMBOLISM IN RATS

By Colucci M.   Sardella L.   Barbanti M.   Calanni F.   Semeraro N.  

Thrombosis Research, Vol. 87, Iss. 5, 1997-09 ,pp. : 441-446

Elsevier

Access to resources Recommend Favorite

TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin

By Hoppensteadt D.A.   Walenga J.M.   Fasanella A.   Jeske W.   Fareed J.  

Thrombosis Research, Vol. 77, Iss. 2, 1995-01 ,pp. : 175-185

Elsevier

Access to resources Recommend Favorite